Celldex develops antibody drugs for mast cell driven and other inflammatory, allergic and autoimmune diseases. It last closed at $27.42 on Nov 20, down 1.93% on the day. The next earnings report for CLDX is expected around Wed, Feb 24, 2027, after the close. For the quarter ended Sep 2026, CLDX reported EPS of -$0.96 on revenue of $0. Over its last 8 reports the stock moved an average of 3.3% the session after earnings. Over the last 12 months CLDX insiders bought $0 of stock on the open market and sold $121K, according to SEC Form 4 filings.
AI Auto Pilots
Is CLDX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CLDX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CLDXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CLDX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 7% below its 20 day and 13% below its 50 day average. It is 20% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $26.57, and the nearest resistance the Pivot at $27.50.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 5.3%/day
Key levels
$45.1452 week high+64.6%
$35.03100 day average+27.8%
$32.93200 day average+20.1%
$30.9250 day average+12.8%
$30.39Swing high (Oct 27)+10.8%
$29.2520 day average+6.7%
$28.35Pivot R1+3.4%
$27.50Pivot+0.3%
$27.42Last close
$26.57Pivot S1−3.1%
$22.3352 week low−18.6%
Indicators
RSI (14)
38.72
Weak, oversold below 30
Neutral
MACD
-0.84
Below its signal line
Bearish
Stochastic
11.8
Near the bottom of its range
Oversold
ADX (14)
21.2
Weak trend
Williams %R
-84.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-157.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−8.2%
Change over 10 sessions
Bearish
ATR (14)
$1.46
Typical daily range, 5.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 12.8%/day
Key levels
$45.1452 week high+64.6%
$35.03100 day average+27.8%
$32.93200 day average+20.1%
$30.9250 day average+12.8%
$30.39Swing high (Oct 27)+10.8%
$29.2520 day average+6.7%
$28.35Pivot R1+3.4%
$27.50Pivot+0.3%
$27.42Last close
$26.57Pivot S1−3.1%
$22.3352 week low−18.6%
Indicators
RSI (14)
38.79
Weak, oversold below 30
Neutral
MACD
-1.26
Below its signal line
Bearish
Stochastic
8.7
Near the bottom of its range
Oversold
ADX (14)
21.3
Weak trend
Williams %R
-95.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-108.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.7%
Change over 10 sessions
Bearish
ATR (14)
$3.51
Typical daily range, 12.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for CLDX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CLDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CLDX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CLDXHow many large options trades hit CLDX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CLDX in the last 90 days.
From SEC Form 4 filings by CLDX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CLDX is in one of them and how their past CLDX trades turned out.
Celldex is a biopharmaceutical company based in Hampton, New Jersey. It develops antibody drugs aimed at diseases driven by mast cells, including chronic urticaria, prurigo nodularis and atopic dermatitis, as well as other severe inflammatory, allergic and autoimmune conditions. Its main candidates are barzolvolimab, a monoclonal antibody, and a bispecific antibody platform for new inflammatory targets. The company has not yet sold any drugs commercially and is focused on patients whose current treatment options are inadequate.